| Entry |
|
|---|
| Name |
Valrocemide (USAN/INN);
Valproyl glycinamide |
|---|
| Formula |
C10H20N2O2
|
|---|
| Exact mass |
200.1525
|
|---|
| Mol weight |
200.28
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02035 Fatty acid antiepileptic
|
|---|
| Efficacy |
Anticonvulsant, Antiepileptic |
|---|
| Comment |
Fatty acid derivative
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02035 Fatty acid antiepileptic
D02718 Valrocemide
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 C1a C 15.2600 -11.2700
2 C1b C 15.2600 -12.6700
3 C1b C 16.4724 -13.3700
4 C1c C 17.6849 -12.6700
5 C1b C 17.6849 -11.2700
6 C1b C 16.4724 -10.5700
7 C1a C 14.0476 -13.3700
8 C5a C 18.9160 -13.3810
9 O5a O 20.1212 -12.6853
10 N1b N 18.9157 -14.7699
11 C1b C 20.1162 -15.4634
12 C5a C 21.3062 -14.7765
13 N1a N 22.4960 -15.4638
14 O5a O 21.3066 -13.3703
BOND 13
1 2 3 1
2 3 4 1
3 4 5 1
4 5 6 1
5 1 6 1
6 2 7 1
7 4 8 1
8 8 9 2
9 8 10 1
10 10 11 1
11 11 12 1
12 12 13 1
13 12 14 2
|
|---|
